Literature DB >> 1699972

Myelin basic protein-specific T cells induce demyelinating experimental autoimmune encephalomyelitis in Buffalo rats.

R E Jones1, D N Bourdette, H Offner, A A Vandenbark.   

Abstract

This is the first description of acute demyelinating experimental autoimmune encephalomyelitis (EAE) induced in rats by myelin basic protein (BP)-specific T lymphocytes without the administration of demyelinating antibodies. BP-specific T cell lines were selected from inbred Buffalo-strain rats (Rt-1b) following techniques used to develop similar lines from Lewis rats (Rt-1l). Unlike those of Lewis rats, the spinal cords of Buffalo rats with T cell line-mediated EAE had prominent perivascular demyelination associated with mononuclear inflammation. Like Lewis rat lines. Buffalo rat BP-specific T cell lines transferred acute, non-relapsing EAE into syngeneic recipients, demonstrating that demyelination in passive acute EAE can occur without subsequent clinical relapses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699972     DOI: 10.1016/0165-5728(90)90053-p

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

Authors:  B L Kotzin; S Karuturi; Y K Chou; J Lafferty; J M Forrester; M Better; G E Nedwin; H Offner; A A Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

2.  Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis.

Authors:  Priya Chaudhary; Gail Marracci; Xiaolin Yu; Danielle Galipeau; Brooke Morris; Dennis Bourdette
Journal:  J Neuroimmunol       Date:  2011-01-07       Impact factor: 3.478

3.  Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation.

Authors:  Feng Mei; Sheng Guo; Yangtao He; Linyun Wang; Hongkai Wang; Jianqin Niu; Jiming Kong; Xinmin Li; Yuzhang Wu; Lan Xiao
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.